News

Zane is usually high on psychedelics whenever Marshall visits him, and Common Side Effects both looks and feels like something Zane might see only when he’s tripping. The characters generally ...
Vyepti, which helps prevent migraine episodes, can cause side effects. Learn about its more common, mild, and serious side effects and how to manage them.
But one side effect of Xiidra that may affect you long term is reduced visual acuity (sharpness of vision). An eye exam determines how well you can see details from a certain distance, which is ...
Botox may cause serious side effects. The following list may not include all possible reported serious side effects of the drug. For more information, you can refer to Botox’s prescribing ...
Caplyta may cause serious side effects, but these are not common. The following list may not include all possible serious side effects of the drug. For more information, you can refer to Caplyta ...
Eventually, the nausea bothered him so much that he gave up on the drug and switched to Viagra. Some men who took Uprima in clinical trials suffered more serious side effects.
It marks the latest side effect related to Ozempic, joining its predecessors “Ozempic face” and “Ozempic butt,” both caused by dramatic changes in body fat.
While hair loss isn't a direct side effect listed in Mounjaro's package insert, a 2022 clinical trial showed that 4.9% to 5.7% of participants taking Mounjaro reported hair loss, compared to 0.9% ...
Nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss, is a “very rare” side effect of treatment with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, ...
Some GLP-1 users report "Ozempic smell," a newfound attraction to sweet perfumes and scents, possibly linked to how the medications affect the brain regions controlling smell and taste.
AS July gets off to a sunny start, many of us are out and about enjoying the weather at festivals, village fetes and garden ...
A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. Following a review ...